Association of neuroendocrine phenotype with platinum chemotherapy outcomes in men with metastatic prostate cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e16532
Abstract: e16532Background: DNA repair defects are common in men with mCRPC, and platinum chemotherapy may have a role in selected patients. We aimed to determine whether neuroendocrine variant prostate canc... read more here.
Keywords: prostate; platinum; association neuroendocrine; neuroendocrine phenotype ... See more keywords